CB
About
Calyx Bio-Ventures holds biotechnology assets. It owns REM technology platform, the rights to use the ACE System technology for gene therapy and transgenics, and a 29% interest in Agrisoma Biosciences, Inc.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 819 investors are based in Vancouver, British Columbia, Canada.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Vancouver, Canada
Contact Information
Find more investors like Calyx
Search Investors